| Outcome Measures: |
Primary: CD34+ Endothelial Progenitor Cell number, Number of CD34+ EPCs. at % of total Mononuclear cells., 24 Weeks|CD34+ Endothelial Progenitor Cell Migration against serum SDF1a gradient, how far the CD34+ migrates in response to SDF1a, 24 Weeks|Gene Expression of CD34+ Endothelial Progenitor Cell number, we will evaluate mRNA gene expression of endothelial Progenitor cell IL-6, IL1β, TNF-alpha, COX2, endothelin 1, p53, p21, and caspase, 24 Weeks | Secondary: Gene Expression of Subcutaneous Adipose cell, We will evaluate mRNA gene expression for mature fat and fat related transcription factors., 24 Weeks|Arterial Stiffness: Pulse Wave Velocity, Velocity of pulse travelling throughout the Body in m/s, 24 Weeks|Arterial Stiffness: Pulse Wave Analysis, Augmentation Index calculated of ratio of reflected waveform from the end arterioles, 24 Weeks|Body Composition: BMI, Body mass index measured using Bio metric Impedance Scale, 24 Weeks|Body Composition: Body Fat Percent, Percent of Body Fat measured using Bio metric Impedance Scale, 24 Weeks|Hip to Waist Ratio, Ratio of Hip to Waist, 24 Weeks|Biochemistry: HbA1c, hemoglobin percent, 24 Weeks|Biochemistry: LDL over HDl Ratio, ratio of LDL over HDL, 24 Weeks
|
| Locations: |
The GW Medical Faculty Associates, Washington, District of Columbia, 20037, United States|Washington VA Medical Center, Washington, District of Columbia, 20422, United States
|
